Northern Trust’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-258,369
| Closed | -$2.58M | – | 4489 |
|
|
2025
Q2 | $2.58M | Buy |
258,369
+8,244
| +3% | +$66.4K | ﹤0.01% | 2844 |
|
|
2025
Q1 | $1.49M | Sell |
250,125
-9,612
| -4% | -$70.6K | ﹤0.01% | 3077 |
|
|
2024
Q4 | $1.99M | Buy |
259,737
+7,881
| +3% | +$67.7K | ﹤0.01% | 3025 |
|
|
2024
Q3 | $2.57M | Buy |
251,856
+10,301
| +4% | +$157K | ﹤0.01% | 2846 |
|
|
2024
Q2 | $3.58M | Sell |
241,555
-8,247
| -3% | -$118K | ﹤0.01% | 2580 |
|
|
2024
Q1 | $3.41M | Sell |
249,802
-7,048
| -3% | -$76.8K | ﹤0.01% | 2703 |
|
|
2023
Q4 | $2.81M | Sell |
256,850
-20,385
| -7% | -$202K | ﹤0.01% | 2810 |
|
|
2023
Q3 | $3.04M | Buy |
277,235
+10,397
| +4% | +$133K | ﹤0.01% | 2711 |
|
|
2023
Q2 | $3.53M | Buy |
266,838
+14,819
| +6% | +$211K | ﹤0.01% | 2690 |
|
|
2023
Q1 | $3.43M | Sell |
252,019
-1,668
| -0.7% | -$29.9K | ﹤0.01% | 2678 |
|
|
2022
Q4 | $4.95M | Buy |
253,687
+11,874
| +5% | +$232K | ﹤0.01% | 2494 |
|
|
2022
Q3 | $4.61M | Buy |
241,813
+8,528
| +4% | +$196K | ﹤0.01% | 2546 |
|
|
2022
Q2 | $4.81M | Buy |
233,285
+35,401
| +18% | +$840K | ﹤0.01% | 2543 |
|
|
2022
Q1 | $6.37M | Buy |
197,884
+12,250
| +7% | +$445K | ﹤0.01% | 2438 |
|
|
2021
Q4 | $8.64M | Buy |
185,634
+9,188
| +5% | +$306K | ﹤0.01% | 2337 |
|
|
2021
Q3 | $4.76M | Buy |
176,446
+3,843
| +2% | +$100K | ﹤0.01% | 2764 |
|
|
2021
Q2 | $4.43M | Sell |
172,603
-20,106
| -10% | -$479K | ﹤0.01% | 2911 |
|
|
2021
Q1 | $6.59M | Buy |
192,709
+60,766
| +46% | +$2.2M | ﹤0.01% | 2566 |
|
|
2020
Q4 | $4.46M | Buy |
131,943
+4,279
| +3% | +$113K | ﹤0.01% | 2747 |
|
|
2020
Q3 | $3.15M | Buy |
+127,664
| New | +$3.43M | ﹤0.01% | 2811 |
|
Other funds holding ITOS
Northern Trust's ITOS Position: Q3 2025 in Review
Northern Trust sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 258,369 shares — an estimated $2.58M sold.
Northern Trust first reported a position in ITOS in Q3 2020 and held it in 20 quarters. The position peaked at $8.64M in Q4 2021. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Northern Trust reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Northern Trust sold 258,369 iTeos Therapeutics shares in Q3 2025, an estimated $2.58M.
- Northern Trust first reported a position in iTeos Therapeutics in Q3 2020 and held it in 20 quarters.
- Northern Trust's iTeos Therapeutics position peaked at $8.64M in Q4 2021.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.